SEC Form 4

FORM 4		UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940	OMB APPROVAL OMB Number: 3235-0287 Estimated average burden hours per response: 0.5
	Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person* SZ INVESTMENTS LLC (Last) (First) (Middle) TWO NORTH RIVERSIDE PLAZA (Street) CHICAGO IL 60606 (City) (State) (Zip)	2. Issuer Name and Ticker or Trading Symbol Adams Respiratory Therapeutics, Inc. [ ARXT ]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director X 10% Owner Officer (give title below) Other (specify below)
	3. Date of Earliest Transaction (Month/Day/Year) 12/14/2005
	4. If Amendment, Date of Original Filed (Month/Day/Year)	6. Individual or Joint/Group Filing (Check Applicable Line) Form filed by One Reporting Person X Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, $0.01 par value	12/14/2005		S		1,715,459(1)	D	$0.01	5,732,975	D(2)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

1. Name and Address of Reporting Person* SZ INVESTMENTS LLC (Last) (First) (Middle) TWO NORTH RIVERSIDE PLAZA (Street) CHICAGO IL 60606 (City) (State) (Zip) Relationship of Reporting Person(s) to Issuer Director X 10% Owner Officer (give title below) Other (specify below)

1. Name and Address of Reporting Person* EGI FUND 99 INVESTORS LLC (Last) (First) (Middle) C/O EQUITY GROUP INVESTMENTS LLC TWO N RIVERSIDE PLZ (Street) CHICAGO IL 60605 (City) (State) (Zip) Relationship of Reporting Person(s) to Issuer Director X 10% Owner Officer (give title below) Other (specify below)

1. Name and Address of Reporting Person* EGI FUND 00 INVESTORS LLC (Last) (First) (Middle) EQUITY GROUP INVESTMENTS LLC TWO NORTH RIVERSIDE PLZ STE 600 (Street) CHICAGO IL 60606 (City) (State) (Zip) Relationship of Reporting Person(s) to Issuer Director X 10% Owner Officer (give title below) Other (specify below)

1. Name and Address of Reporting Person* EGI FUND 01 INVESTORS LLC (Last) (First) (Middle) 2 NORTH RIVERSIDE PLZ SUITE 600 (Street) CHICAGO IL 60606 (City) (State) (Zip) Relationship of Reporting Person(s) to Issuer Director X 10% Owner Officer (give title below) Other (specify below)

1. Name and Address of Reporting Person* EGI FUND 02 04 INVESTORS LLC (Last) (First) (Middle) C/O EQUITY GROUP INVESTMENTS 2 N RIVERSIDE PLZ (Street) CHICAGO IL 60606 (City) (State) (Zip) Relationship of Reporting Person(s) to Issuer Director X 10% Owner Officer (give title below) Other (specify below)

1. Name and Address of Reporting Person* EGI-Managing Member (01), L.L.C. (Last) (First) (Middle) TWO NORTH RIVERSIDE PLAZA SUITE 600 (Street) CHICAGO IL 60606 (City) (State) (Zip) Relationship of Reporting Person(s) to Issuer Director X 10% Owner Officer (give title below) Other (specify below)

1. Name and Address of Reporting Person* EGI MANAGING MEMBER 02 04 LLC (Last) (First) (Middle) EQUITY GROUP INVESTMENTS LLC 2 N RIVERSIDE PALZA STE 600 (Street) CHICAGO IL 60606 (City) (State) (Zip) Relationship of Reporting Person(s) to Issuer Director X 10% Owner Officer (give title below) Other (specify below)

1. Name and Address of Reporting Person* CHAI TRUST CO LLC (Last) (First) (Middle) TWO NORTH RIVERSIDE PLAZA SUITE 600 (Street) CHICAGO IL 60606 (City) (State) (Zip) Relationship of Reporting Person(s) to Issuer Director X 10% Owner Officer (give title below) Other (specify below)

Explanation of Responses:

1. Such 1,715,459 shares of Common Stock were sold to underwriters of the Issuer in connection with a registered secondary offering of the Issuer as follows: 483,642 shares were sold by EGI-Fund (99) Investors, L.L.C. ("Fund 99"); 338,689 of such shares were sold by EGI-Fund (00) Investors, L.L.C. ("Fund 00"); 99,701 of such shares were sold by EGI-Fund (01) Investors, L.L.C. ("Fund 01"); and 793,427 of such shares were sold by EGI-Fund (02-04) Investors, L.L.C. ("Fund 02-04")

2. 1,616,308 of the shares of Common Stock remaining are held by Fund 99; 1,131,881 of such shares are held by Fund 00; 333,194 of such shares are Fund 01; and 2,651,592 of such shares are held by Fund 02-04. EGI-Managing Member (01), L.L.C. is the managing member of Fund 01 ("MM-01"). EGI-Managing Member (02-04), L.L.C. ("MM-02-04") is the managing member of Fund 02-04. SZ Investments, L.L.C. ("SZ") is the managing member of each of Fund 99, Fund 00, MM-01 and MM-02-04. Chai Trust Company, L.L.C. is the trustee of trusts which have an indirect ownership interest in each of Fund 99, Fund 00, Fund 01, Fund 02-04, MM-01, MM-02-04 and SZ.

Remarks:

The address for each Reporting Person is Two North Riverside Plaza, Suite 600, Chicago, Illinois 60606

	Donald J. Liebentritt	12/14/2005
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.